To view the conference agenda, please click on the link below.

Download Conference Agenda

 Conference Highlights

Our faculty will include industry and provider experts, as well as key Federal and State officials who help administer the 340B, Medicaid drug rebate, and Medicare Part D programs. The Office of Pharmacy Affairs will provide presentations and will be available each day to answer your questions. Topics to be discussed include:

• Concurrent introductory classes on 340B and patient assistance programs (PAPs)
• Potential changes to the 340B definition of patient
• Impact of new drug pricing laws on the 340B and Medicaid drug rebate programs, including the mandatory disclosure of average manufacturer price, changes to nominal price protections and treatment of authorized generics
• Update on Inspector General reports and other government studies
• Status report on efforts to recover 340B overcharges, including various legal and legislative action
• Efforts to prevent drug diversion, including federal investigations and enforcement
• President’s proposal to increase funding for OPA and reform the best price calculation used to determine 340B discounts and Medicaid rebates
• Update on the best price exemption for inpatient pharmaceuticals
• Federal plans to expand contract pharmacy options under 340B
• Contracting challenges under Medicare Part D, restructured PAP models, and other developments relevant to 340B stakeholders
• Medicaid billing procedures used by 340B providers for both self-administered and physician-administered drugs
• Update on the 340B prime vendor program, including new contracts with manufacturers for subceiling discounts
• Latest news on the future of PAPs
• Children’s hospitals and other new entities eligible for the 340B program
• State and local government partnerships with 340B providers

Use the link below to download the conference agenda.

• Download Conference Agenda